Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Androgens affect the function and health of the endometrium.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Anabolic agents can cause cardiovascular and behavioral issues in athletes.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

The method accurately measures sex hormones in human plasma but can have small errors.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Treatments for hair loss vary, but cell-based options may be the future.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.